458 related articles for article (PubMed ID: 23652165)
41. Evaluation of Guillain-Barré Syndrome among recipients of influenza vaccine in 2000 and 2001.
Burwen DR; Ball R; Bryan WW; Izurieta HS; La Voie L; Gibbs NA; Kliman R; Braun MM
Am J Prev Med; 2010 Oct; 39(4):296-304. PubMed ID: 20837279
[TBL] [Abstract][Full Text] [Related]
42. Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review.
Isai A; Durand J; Le Meur S; Hidalgo-Simon A; Kurz X
Vaccine; 2012 Nov; 30(49):7123-9. PubMed ID: 23022149
[TBL] [Abstract][Full Text] [Related]
43. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.
Lasky T; Terracciano GJ; Magder L; Koski CL; Ballesteros M; Nash D; Clark S; Haber P; Stolley PD; Schonberger LB; Chen RT
N Engl J Med; 1998 Dec; 339(25):1797-802. PubMed ID: 9854114
[TBL] [Abstract][Full Text] [Related]
44. Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus.
Lei T; Siu KL; Kok KH; Chan KH; Chan EY; Hung IF; To KK; Li PC; Zhou J; Zheng BJ; Yuen KY; Wang M; Jin DY
Vaccine; 2012 Mar; 30(16):2605-10. PubMed ID: 22342549
[TBL] [Abstract][Full Text] [Related]
45. Guillain-Barré Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018-2019 Season.
Perez-Vilar S; Hu M; Weintraub E; Arya D; Lufkin B; Myers T; Woo EJ; Lo AC; Chu S; Swarr M; Liao J; Wernecke M; MaCurdy T; Kelman J; Anderson S; Duffy J; Forshee RA
J Infect Dis; 2021 Feb; 223(3):416-425. PubMed ID: 33137184
[TBL] [Abstract][Full Text] [Related]
46. Guillain-Barré syndrome following H1N1 immunization in a pediatric patient.
Tremblay ME; Closon A; D'Anjou G; Bussières JF
Ann Pharmacother; 2010; 44(7-8):1330-3. PubMed ID: 20484170
[TBL] [Abstract][Full Text] [Related]
47. Recurrent Guillain-Barre syndrome following vaccination.
Baxter R; Lewis N; Bakshi N; Vellozzi C; Klein NP;
Clin Infect Dis; 2012 Mar; 54(6):800-4. PubMed ID: 22267712
[TBL] [Abstract][Full Text] [Related]
48. Pandemic vaccines and small excess of Guillain-Barre cases.
BMJ; 2013 Mar; 346():f1714. PubMed ID: 23516147
[No Abstract] [Full Text] [Related]
49. Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009-2010 season in the active component U.S. military and civilians aged 17-44years reported to the Vaccine Adverse Event Reporting System.
Bardenheier BH; Duderstadt SK; Engler RJ; McNeil MM
Vaccine; 2016 Aug; 34(37):4406-14. PubMed ID: 27449076
[TBL] [Abstract][Full Text] [Related]
50. Invited commentary: Influenza vaccine and Guillain-Barre syndrome--is there a risk?
Nelson KE
Am J Epidemiol; 2012 Jun; 175(11):1129-32. PubMed ID: 22582208
[TBL] [Abstract][Full Text] [Related]
51. Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database.
Stowe J; Andrews N; Wise L; Miller E
Am J Epidemiol; 2009 Feb; 169(3):382-8. PubMed ID: 19033158
[TBL] [Abstract][Full Text] [Related]
52. [Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far].
Press R; Andersen O
Lakartidningen; 2010 Mar 10-16; 107(10):666-7. PubMed ID: 20402249
[No Abstract] [Full Text] [Related]
53. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
Souayah N; Nasar A; Suri MF; Qureshi AI
J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
[TBL] [Abstract][Full Text] [Related]
54. Guillain-Barré syndrome and H1N1 influenza vaccine in UK children.
Verity C; Stellitano L; Winstone AM; Andrews N; Stowe J; Miller E
Lancet; 2011 Oct; 378(9802):1545-6. PubMed ID: 22035553
[No Abstract] [Full Text] [Related]
55. Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination.
Galeotti F; Massari M; D'Alessandro R; Beghi E; Chiò A; Logroscino G; Filippini G; Benedetti MD; Pugliatti M; Santuccio C; Raschetti R;
Eur J Epidemiol; 2013 May; 28(5):433-44. PubMed ID: 23543123
[TBL] [Abstract][Full Text] [Related]
56. Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries.
Goud R; Lufkin B; Duffy J; Whitaker B; Wong HL; Liao J; Lo AC; Parulekar S; Agger P; Anderson SA; Wernecke M; MaCurdy TE; Weintraub E; Kelman JA; Forshee RA
JAMA Intern Med; 2021 Dec; 181(12):1623-1630. PubMed ID: 34724025
[TBL] [Abstract][Full Text] [Related]
57. Safety of influenza vaccination in patients with myasthenia gravis: a population-based study.
Zinman L; Thoma J; Kwong JC; Kopp A; Stukel TA; Juurlink DN
Muscle Nerve; 2009 Dec; 40(6):947-51. PubMed ID: 19902540
[TBL] [Abstract][Full Text] [Related]
58. The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis.
Huang WT; Huang WI; Huang YW; Hsu CW; Chuang JH
Vaccine; 2012 Mar; 30(12):2168-72. PubMed ID: 22265861
[TBL] [Abstract][Full Text] [Related]
59. Simulation study of the effect of influenza and influenza vaccination on risk of acquiring Guillain-Barré syndrome.
Hawken S; Kwong JC; Deeks SL; Crowcroft NS; McGeer AJ; Ducharme R; Campitelli MA; Coyle D; Wilson K
Emerg Infect Dis; 2015 Feb; 21(2):224-31. PubMed ID: 25625590
[TBL] [Abstract][Full Text] [Related]
60. A simulation study of the statistical power and signaling characteristics of an early season sequential test for influenza vaccine safety.
Forshee RA; Hu M; Arya D; Perez-Vilar S; Anderson SA; Lo AC; Swarr M; Wernecke M; MaCurdy T; Chu S; Kelman J
Pharmacoepidemiol Drug Saf; 2019 Aug; 28(8):1077-1085. PubMed ID: 31222967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
